Homeresearch

research

biotech

Base to Base biotech podcast 56: GRIN genes and relapsing MS

Jim Cornall - April 24, 2026

biotech

Positive first-in-human data for IVF-related embryo implantation failure treatment

Jim Cornall - April 23, 2026

biotech

New company plans to replace daily injections with implant

Jim Cornall - April 23, 2026

biotech

UCB adds epilepsy drug through Neurona Therapeutics acquisition

Jim Cornall - April 23, 2026

photonics

Super photon research could lead to tap-proof communication

Jim Cornall - September 6, 2024

photonics

Lighting the way for quantum innovation

Jim Cornall - August 30, 2024

research

Paving the way for improved fuel cell vehicles

Jim Cornall - August 14, 2024

biotech

European Inventor Award 2024 finalists revealed

Jim Cornall - May 29, 2024

energy

Researchers hail solar cell technology advancement

Jim Cornall - May 15, 2024

AI

Boost for security in artificial intelligence and image processing

Jim Cornall - April 29, 2024

research

New opportunities for 2D material

Jim Cornall - March 15, 2024

research

A “quantum leap” at room temperature

Jim Cornall - February 16, 2024

1...345 Page 4 of 5

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 56: GRIN genes and relapsing MS

Jim Cornall - April 24, 2026 0

This week, our conversations are with Bruce Leuchter, co-founder, president, CEO of Neurvati Neurosciences and GRIN Therapeutics; and Daniel Vitt, CEO of Immunic. Base to...

Positive first-in-human data for IVF-related embryo implantation failure treatment

biotech Jim Cornall - April 23, 2026 0

New company plans to replace daily injections with implant

biotech Jim Cornall - April 23, 2026 0

UCB adds epilepsy drug through Neurona Therapeutics acquisition

biotech Jim Cornall - April 23, 2026 0

Mechanism ‘opens new era’ for targeted cancer therapy

biotech Jim Cornall - April 22, 2026 0